THE INTERSECTION OF BRAIN SCIENCE & HUMAN POTENTIALPartner with us
neurofeedback.com
The newsletter
← Research & Evidence
Positive with limitationsClinical active-comparator cohort study with multimodal neuroimaging

Synergistic modulation of the dorsolateral prefrontal cortex and precuneus enhances cognitive recovery in mild cognitive impairment: A multimodal neuroimaging study

Published October 20, 2026. People receiving sequential stimulation of two cognitive-network targets improved more on several short-term cognitive measures than people receiving stimulation at one target. Because both groups received active treatment and the accessible abstract does not describe randomization, masking or follow-up after the 10-day course, this is a promising protocol-comparison result rather than proof of benefit over no stimulation.

Guo Z, Chen W, Xie J, Pu Y, Yang H, Mu Q.
Neural Regeneration Research · Publication date: 2026-10-20
Added to site: 2026-10-21
DOI: 10.4103/nrr.nrronline-d-26-00876

Published online October 20, 2026. Added to Neurofeedback.com October 21, 2026.

Modalities
rTMS, Multisite stimulation, Neuroimaging
Clinical focus
Mild cognitive impairment, Cognition, Network-informed targeting
Population
People with mild cognitive impairment
Sample
101 completers: 50 single-site and 51 multisite
Intervention / method
Ten days of rTMS over the left dorsolateral prefrontal cortex alone or sequentially over the left dorsolateral prefrontal cortex and precuneus
Comparator
Multisite active rTMS versus single-site active rTMS; no sham or no-treatment arm

Clinician summary

Multisite treatment favored single-site treatment for MMSE (group-by-time F(99)=25.08, p<.001), MoCA (F(99)=6.17, p=.015), immediate verbal recall (F(99)=6.03, p=.016) and animal fluency (F(99)=8.13, p=.005). Broader MRI changes and correlations with cognitive change were reported, but the associations do not establish mediation or neural repair.

How to interpret the findings

The abstract describes two active cohorts but does not state random allocation or masking. There was no sham or no-treatment control, the intervention lasted 10 days, durability and functional daily-life outcomes were not reported, and adverse-event details were unavailable in the checked abstract. Imaging associations are exploratory and noncausal.

Equipment and disclosures

The accessible abstract did not identify a device manufacturer. This summary does not attribute the equipment to BrainMaster or any vendor.

Funding and conflict details were not available in the checked abstract or retained PubMed record. No correction, retraction or concern relation appeared in the retained Crossref record; this is a bounded check. AI-assisted review.

Related evidence

Compare findings from the same clinical area, including mixed results.

Abstract checked · Checked 2026-10-21

Summary prepared with AI assistance. Source verification does not imply an independent replication or a clinician's endorsement. Read our review method.